ALLISON ENESS: Open Payments
NPI 1962490284 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 15 payments from 6 companies in 2025. Trend: 2023 $356 · 2024 $266 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 6 | $140 |
| Astellas Pharma US Inc | 3 | $68 |
| Octapharma USA, Inc. | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: ZURZUVAE, Veozah, FIBRYGA, MYFEMBREE, Mirena, Lynkuet, GARDASIL 9.
Industry payments across IA — which companies pay providers there.
